The drug works to prevent strokes in people with a heart-rhythm disorder called atrial fibrillation. An FDA decision could come as early as March 28, 2012.
Related Articles on FDA Approvals:
FDA Approves Expansion of BioMarin Pharma Plant
FDA Approves Philips’ PET and MRI Whole Body Scanning System
FDA Approves New Boston Scientific Heart Stent
